Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

CLSD holding history

Clearside Biomedical, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLSD overviewAll 13F holders of CLSDFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CLSD by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−52,741−100.0%Sold outHolders
Q3 202552,741$209.4K<0.1%00.0%UnchangedConverted for a 1-for-15 splitHolders
Q2 2025790,373$632.4K<0.1%−1,874−0.2%ReducedHolders
Q1 2025792,247$727.4K<0.1%+28,189+3.7%AddedHolders
Q4 2024764,058$726.0K<0.1%+32,672+4.5%AddedHolders
Q3 2024731,386$929.0K<0.1%+59,089+8.8%AddedHolders
Q2 2024672,297$874.2K<0.1%+30,084+4.7%AddedHolders
Q1 2024642,213$982.8K<0.1%+151,523+30.9%AddedHolders
Q4 2023490,690$574.3K<0.1%00.0%UnchangedHolders
Q3 2023490,690$427.0K<0.1%−8,517−1.7%ReducedHolders
Q2 2023499,207$559.1K<0.1%−30,890−5.8%ReducedHolders
Q1 2023530,097$551.3K<0.1%00.0%UnchangedHolders
Q4 2022530,097$593.0K<0.1%+4,790+0.9%AddedHolders
Q3 2022525,307$593.0K<0.1%+1,316+0.3%AddedHolders
Q2 2022523,991$770.0K<0.1%+34,062+7.0%AddedHolders
Q1 2022489,929$1.12M<0.1%+3,287+0.7%AddedHolders
Q4 2021486,642$1.34M<0.1%00.0%UnchangedHolders
Q3 2021486,642$2.92M<0.1%+63,101+14.9%AddedHolders
Q2 2021423,541$2.06M<0.1%+58,818+16.1%AddedHolders
Q1 2021364,723$900.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.